The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.
about
Obstructive sleep apnea syndrome and fatty liver: association or causal link?Nonalcoholic fatty liver disease as a multi-systemic diseaseTreating morbid obesity in cirrhosis: A quest of holy grailThe therapy of insulin resistance in other diseases besides type 2 diabetesMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)The adipokine/ceramide axis: key aspects of insulin sensitizationInhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in miceThe goose genome sequence leads to insights into the evolution of waterfowl and susceptibility to fatty liverLongitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice.High fat feeding induces hepatic fatty acid elongation in mice.Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.Dietary recommendations for patients with nonalcoholic fatty liver diseaseDistinct metabolic effects following short-term exposure of different high-fat diets in male and female miceAutophagy protects against palmitate-induced apoptosis in hepatocytesMolecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.Hepatocyte death: a clear and present danger.Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discoveryAlteration of hepatic but not renal transporter expression in diet-induced obese miceThe heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetesEucommia ulmoides Oliver extract, aucubin, and geniposide enhance lysosomal activity to regulate ER stress and hepatic lipid accumulationLipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic liversRegulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs.Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.The role of metformin in the management of NAFLDHugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease.Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance.A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.Role of ceramides in nonalcoholic fatty liver diseaseHepatitis C virus infection and nonalcoholic steatohepatitisDocosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cellsInteractions between hepatic iron and lipid metabolism with possible relevance to steatohepatitisEnhanced expression of glucose-regulated protein 78 correlates with malondialdehyde levels during the formation of liver cirrhosis in ratsHigh-sensitivity C-reactive protein and liver enzymes in individuals with Metabolic Syndrome in Talca, Chile.Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitisLabel-free imaging and analysis of the effects of lipolysis products on primary hepatocytes.
P2860
Q24612841-86B301B9-AEF9-4258-88E3-6E06B147AAA1Q26749290-FA274C20-400D-4987-8A15-3A36C751BE9DQ26775811-9A241E4A-AC24-4DDF-9527-2B4519931749Q26822399-8A96EEE0-D122-4CF2-8A5A-201DBB1792C9Q27007515-DC23F48A-C275-4CD5-8797-44ABDFFBAEF1Q27025041-F922ACBE-9133-494B-A0D8-43DC937DB733Q28385478-CA4279C7-0A20-4A77-AEAB-7FF80A47B658Q28648090-C4319448-8638-4695-ADC1-944E0FCB5E80Q30586373-38F0C93B-34AF-45E1-9CCC-046EDA7CA8B6Q33474784-478604B1-5A16-474F-A224-AF2E60916BD1Q33526310-C0F51FBE-FE22-4AC8-805B-7017316D0C87Q33636695-6A573628-1872-4C9F-8BE6-CF70EBC2161DQ33709596-938B2FBB-D08B-4717-8AF7-F5E4B715A282Q33712340-DE25CC45-4A4A-4319-9837-B5E2E961C216Q33755566-1D09EF8B-1EE9-42AC-8774-D578805517D8Q33858409-C5DB47ED-78ED-460D-80BC-BD877B4CDD6DQ34094150-FE080CAE-0278-4901-86EB-0474406C45D5Q34103693-5CF319B7-49A9-4A73-A931-B9E7AF3E083EQ34147508-FF555A28-76D0-453A-B21E-33D0045225FBQ34997512-B9061E92-4FF4-4D28-B2C9-A5F960B2F366Q35002476-3EEB2BF7-A3B9-4610-8D55-6BA3D4D4015CQ35048289-B92557F6-1694-4B3E-ACA6-70CEFED84428Q35069547-6BC6FE73-AABE-4A95-9858-D0F432D31B85Q35172447-8F43F714-E760-45BC-990F-BE03253793FDQ35332874-B9BBA307-869A-48C4-A0A0-CF0840DA8F47Q35601541-B67E4B92-D756-4A3A-BD11-C8BF3BDFC983Q35614956-6879A4F5-B84A-40F9-970C-B3F1146D892BQ35753386-D1905512-525D-49EB-B6B2-DC174047737BQ35887169-8A1C7878-FD2F-4DB9-B2C8-E1467E8A9A03Q35933771-623FBEE4-3E48-4FA5-A26B-EF49AA71A405Q36129432-974315F1-BC4C-43BA-B004-368089685261Q36179898-37AC8F3D-664E-4D3D-8942-6A8CC2C3564FQ36192607-3CD4C0E6-E190-4040-8C3E-188CC7A820E7Q36233818-287DD093-5F7D-4F3F-8B0F-3B60BB2001FAQ36335611-ECDBD51A-2DFC-42D9-97E4-0F5F9D92817BQ36375377-D0709D3D-3010-4FF1-BE00-C25CD9325C75Q36505119-8226ABFB-1ED1-43EA-81AC-6AA0DDADCD32Q36530010-9F9857EE-BBEE-48E3-BFBF-7C8F434F3627Q36818022-8846F1F5-7A80-4198-8E20-9408F9897D16Q36966171-471AA83B-58FF-4212-BC4C-5C9EDAB17A17
P2860
The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The role of fatty acids in the ...... alcoholic fatty liver disease.
@en
type
label
The role of fatty acids in the ...... alcoholic fatty liver disease.
@en
prefLabel
The role of fatty acids in the ...... alcoholic fatty liver disease.
@en
P2860
P1476
The role of fatty acids in the ...... alcoholic fatty liver disease.
@en
P2093
Christopher L Gentile
Michael J Pagliassotti
P2860
P304
P356
10.1016/J.JNUTBIO.2007.10.001
P577
2008-04-21T00:00:00Z